A new study published in Neurology Open Access suggests that maintaining healthy vitamin D levels during midlife may be associated with lower levels of tau protein decades later, a key biological marker of Alzheimer’s disease. The findings add to growing evidence that factors influencing brain health may begin long before memory problems develop.
The study examined whether vitamin D status around age 40 was associated with the later accumulation of tau and amyloid beta, the two hallmark proteins linked to Alzheimer’s disease. Although previous research has connected low vitamin D levels with a higher risk of dementia in older adults, relatively little has been known about whether vitamin D may influence brain changes in younger, cognitively healthy individuals.
Inside the Framingham Heart Study
The researchers analyzed data from 793 participants enrolled in the long-running Framingham Heart Study in the United States. None of the participants had dementia when they entered the study. At an average age of 39, each participant provided a blood sample that allowed researchers to measure serum vitamin D concentrations.
Approximately 16 years later, about 430 participants underwent positron emission tomography (PET) brain scans to measure deposits of tau and amyloid beta, the two proteins most closely associated with Alzheimer’s disease. This long-term design allowed the researchers to examine whether vitamin D levels measured during early midlife were related to biological changes detected years later.
Higher vitamin D was associated with lower tau
The analysis found that participants with higher vitamin D levels in their late 30s were more likely to have lower levels of tau protein on PET scans performed during their mid-50s.
Tau proteins can form tangles inside nerve cells, disrupting communication between neurons and contributing to the progression of Alzheimer’s disease. The accumulation of tau has been closely linked to cognitive decline and disease severity.
By contrast, the researchers did not observe a significant association between vitamin D levels and amyloid beta accumulation. According to the authors, this is the first study to demonstrate a relationship between blood vitamin D concentrations and brain imaging markers of preclinical Alzheimer’s disease in relatively young, cognitively healthy adults.
The findings do not prove vitamin D prevents dementia
The researchers emphasize that the study was observational and cannot establish that vitamin D directly reduces tau accumulation or prevents Alzheimer’s disease.
Other factors commonly associated with higher vitamin D levels, including greater outdoor activity, healthier diets, or overall lifestyle differences, may also contribute to the observed relationship.
Lead author Emer McGrath of the University of Galway stressed that the findings demonstrate an association rather than a cause-and-effect relationship. Determining whether vitamin D supplementation can directly influence brain health will require randomized clinical trials involving younger adults before symptoms of cognitive decline appear.
Why midlife may be an important window
Previous clinical trials involving older adults have produced less encouraging results. For example, a French study involving people over the age of 70 with memory complaints found that one year of vitamin D supplementation did not reduce tau accumulation.
The researchers suggest that these interventions may have begun after Alzheimer’s-related brain changes were already well established. The new findings support the possibility that midlife represents a critical period during which modifying risk factors may have greater potential to influence disease processes.
If future clinical trials confirm these findings, maintaining adequate vitamin D levels over many years could become one component of broader strategies aimed at reducing Alzheimer’s risk before symptoms develop.
What the findings could mean
The researchers caution that excessive vitamin D intake can lead to toxicity and should not be viewed as a preventive treatment without medical guidance. However, vitamin D deficiency remains common worldwide, particularly in regions with limited sunlight, and maintaining healthy levels is already widely recommended for bone health, immune function, and overall well-being.
The findings also contribute to an expanding body of research suggesting that modifiable lifestyle factors—including blood pressure, physical activity, sleep, and possibly vitamin D status—may influence long-term brain health decades before dementia develops.
Although further research is needed, the study highlights the growing importance of identifying early-life strategies that could help reduce Alzheimer’s disease risk. As dementia continues to affect millions of people worldwide, understanding when and how protective factors influence the brain may prove just as important as discovering new treatments.
